Oculis Holding AG (OCS) Other Gross PP&E Adjustments (2022 - 2026)

Oculis Holding AG's (OCS) quarterly Other Gross PP&E Adjustments came in at -$3.0 million in Q1 2026, down 122.93% year-on-year from $13.2 million in Q1 2025, and up 2.0% quarter-over-quarter from -$3.1 million in Q4 2025.

Oculis Holding AG (OCS) Other Gross PP&E Adjustments (2022 - 2026) Analysis & Trends

Oculis Holding AG's Other Gross PP&E Adjustments history runs 5 years deep, the most recent figure standing at -$3.0 million for Q1 2026.

  • On a quarterly basis, Other Gross PP&E Adjustments fell 122.93% year-over-year to -$3.0 million in Q1 2026; TTM through Mar 2026 was -$3.0 million, a 122.93% decrease from a year earlier, with the FY2025 full-year figure at -$3.0 million, down 100.57% from the prior year.
  • Other Gross PP&E Adjustments climbed to -$3.0 million in Q1 2026 per OCS's latest filing, from -$3.1 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at -$786820.6 in Q4 2022 and bottomed at -$3.2 million in Q3 2025.
  • The 5-year median for Other Gross PP&E Adjustments is -$1.4 million (2025), against an average of -$1.6 million.
  • Across the five-year window, Other Gross PP&E Adjustments advanced 13.88% in 2025 and tumbled 122.93% in 2026, its largest moves.
  • Year by year, Other Gross PP&E Adjustments stood at -$786820.6 in 2022, then fell by 8.18% to -$851152.6 in 2023, then slumped by 74.75% to -$1.5 million in 2024, then sank by 107.18% to -$3.1 million in 2025, then increased by 2.0% to -$3.0 million in 2026.
  • Per Business Quant, the three latest OCS Other Gross PP&E Adjustments figures stand at -$3.0 million (Q1 2026), -$3.1 million (Q4 2025), and -$3.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -3.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - 35.73 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -1.69 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -67.74 Mn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn -189.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.02 Mn
Mar 31, 2026 -3.02 Mn
Dec 31, 2025 -3.08 Mn
Dec 31, 2025 -3.08 Mn
Sep 30, 2025 -3.22 Mn
Sep 30, 2025 -3.22 Mn
Jun 30, 2025 -1.40 Mn
Jun 30, 2025 -1.40 Mn
Mar 31, 2025 -1.35 Mn
Mar 31, 2025 -1.35 Mn
Dec 31, 2024 -1.49 Mn
Dec 31, 2024 -1.49 Mn
Sep 30, 2024 -1.60 Mn
Sep 30, 2024 -1.60 Mn
Jun 30, 2024 -1.62 Mn
Jun 30, 2024 -1.62 Mn
Mar 31, 2024 -823,745.58
Mar 31, 2024 -823,745.58
Dec 31, 2023 -851,152.63
Dec 31, 2023 -851,152.63